{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,28]],"date-time":"2025-08-28T12:46:48Z","timestamp":1756385208104,"version":"3.44.0"},"reference-count":16,"publisher":"BMJ","issue":"3","content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["DTB"],"published-print":{"date-parts":[[2014,3]]},"abstract":"<jats:p>Every month, <jats:italic>DTB<\/jats:italic> scans sources of information on treatments, disease management and other healthcare topics for key items to bring to our readers' attention and help them keep up to date. To do this, we produce succinct, contextualised summaries of the information concerned. We also include comments on, for example, the strengths of the information, whether it contains anomalies, ambiguities, apparent error or omissions, or whether or how it affects current practice.<\/jats:p>","DOI":"10.1136\/dtb.2014.3.0239","type":"journal-article","created":{"date-parts":[[2014,3,1]],"date-time":"2014-03-01T02:07:17Z","timestamp":1393639637000},"page":"26-29","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":1,"title":["DTB Select: 3 | March 2014"],"prefix":"10.1136","volume":"52","member":"239","published-online":{"date-parts":[[2014,2,28]]},"reference":[{"key":"2025082623311534000_52.3.26.1","unstructured":"European Medicines Agency, 2014. PRAC recommends suspending use of Protelos\/Osseor [online]. Available: http:\/\/www.ema.europa.eu\/ema\/index.jsp?curl=pages\/news_and_events\/news\/2014\/01\/news_detail_002005.jsp&mid=WC0b01ac058004d5c1 [Accessed 19 February 2014]."},{"key":"2025082623311534000_52.3.26.2","unstructured":"Protelos. Summary of product characteristics, EU. Servier Laboratories Limited, December 2013."},{"key":"2025082623311534000_52.3.26.3","unstructured":"Medicines and Healthcare products Regulatory Agency. Strontium ranelate (Protelos): risk of serious cardiac disorders\u2014restricted indications, new contraindications, and warnings. Drug Safety Update 2013; 6 (9): pS1 [online]. Available: http:\/\/www.mhra.gov.uk\/Safetyinformation\/DrugSafetyUpdate\/CON266148 [Accessed 19 February 2014]."},{"key":"2025082623311534000_52.3.26.4","unstructured":"European Medicines Agency , 2014. European Medicines Agency recommends that Protelos\/Osseor remain available but with further restrictions [online]. Available: http:\/\/www.ema.europa.eu\/ema\/index.jsp?curl=pages\/news_and_events\/news\/2014\/02\/news_detail_002031.jsp&mid=WC0b01ac058001d126 [Accessed 24 February 2014]."},{"key":"2025082623311534000_52.3.26.5","unstructured":"Health and Social Care Information Centre, 2013. Prescription cost analysis England 2012 [online]. Available: http:\/\/www.hscic.gov.uk\/catalogue\/PUB10610\/pres-cost-anal-eng-2012a-rep.pdf [Accessed 19 February 2014]."},{"key":"2025082623311534000_52.3.26.6","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2013.280490"},{"key":"2025082623311534000_52.3.26.7","unstructured":"Medicines and Healthcare products Regulatory Agency, 2013. New drug driving offence\u2014implications for medicines packaging [online]. Available: http:\/\/www.mhra.gov.uk\/home\/groups\/comms-ic\/documents\/regulatorynews\/con350700.pdf [Accessed 19 February 2014]."},{"key":"2025082623311534000_52.3.26.8","doi-asserted-by":"crossref","unstructured":"James PA . Evidence-based guideline for the management of high blood pressure in adults: report from the panel members appointed to the Eighth Joint National Committee (JNC 8). JAMA [Epub ahead of print] 18 December 2013; DOI:10.1001\/jama.2013.284427.","DOI":"10.1001\/jama.2013.284427"},{"key":"2025082623311534000_52.3.26.9","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2013.284432"},{"key":"2025082623311534000_52.3.26.10","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1001\/jama.2013.284430","article-title":"Recommendations for treating hypertension - what are the right goals and purposes?","volume":"311","author":"Peterson","year":"2014","journal-title":"JAMA"},{"key":"2025082623311534000_52.3.26.11","unstructured":"Scottish Intercollegiate Guidelines Network, 2013. Management of chronic pain [online]. Available: http:\/\/www.sign.ac.uk\/pdf\/SIGN136.pdf [Accessed 19\u00a0February 2014]."},{"key":"2025082623311534000_52.3.26.12","unstructured":"Medicines and Healthcare products Regulatory Agency. Rituximab: screen for hepatitis B virus before treatment. Drug Safety Update 2013; 7 (5): pA1 [online]. Available: http:\/\/www.mhra.gov.uk\/Safetyinformation\/DrugSafetyUpdate\/CON350669 [Accessed 19 February 2014]."},{"key":"2025082623311534000_52.3.26.13","doi-asserted-by":"crossref","unstructured":"Thompson M . Duration of symptoms of respiratory tract infections in children: systematic review. BMJ 2013; 347: pf7027.","DOI":"10.1136\/bmj.f7027"},{"key":"2025082623311534000_52.3.26.14","unstructured":"National Institute for Health and Care Excellence, 2008. Respiratory tract infections\u2014antibiotic prescribing: prescribing of antibiotics for self-limiting respiratory tract infections in adults and children in primary care [online]. Available: http:\/\/publications.nice.org.uk\/respiratory-tract-infections-antibiotic-prescribing-cg69 [Accessed 19 February 2014]."},{"key":"2025082623311534000_52.3.26.15","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2013.282834"},{"key":"2025082623311534000_52.3.26.16","unstructured":"Medicines and Healthcare products Regulatory Agency. Clopidogrel: risk of acquired haemophilia. Drug Safety Update 2013; 7 (5): pA2 [online]. Available: http:\/\/www.mhra.gov.uk\/Safetyinformation\/DrugSafetyUpdate\/CON350671 [Accessed 19 February 2014]."}],"container-title":["Drug and Therapeutics Bulletin"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/dtb.2014.3.0239","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,27]],"date-time":"2025-08-27T06:31:27Z","timestamp":1756276287000},"score":1,"resource":{"primary":{"URL":"https:\/\/dtb.bmj.com\/lookup\/doi\/10.1136\/dtb.2014.3.0239"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,2,28]]},"references-count":16,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2014,3,13]]},"published-print":{"date-parts":[[2014,3]]}},"alternative-id":["10.1136\/dtb.2014.3.0239"],"URL":"https:\/\/doi.org\/10.1136\/dtb.2014.3.0239","relation":{},"ISSN":["0012-6543","1755-5248"],"issn-type":[{"type":"print","value":"0012-6543"},{"type":"electronic","value":"1755-5248"}],"subject":[],"published":{"date-parts":[[2014,2,28]]}}}